Production

Ind-Swift Limited - Jawaharpur, Derabassi is the Ace unit of Ind-Swift Limited, was created in the year 2005 with an aim to globalize the Ind-Swift brand for finished dosage forms. We are a 100% Export Oriented Unit dealing in regulated markets having approval like MHRA, TGA & GLC etc.

OPEN POSITIONS for Formulation Site

Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.

Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.

Hetero Drugs is an Indian pharmaceutical company and the world’s largest producer of anti-retroviral drugs. Hetero’s business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics. Globally renowned, vertically integrated pharmaceutical player engaged in Research and Development (R&D), manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas.

FDC is a people-oriented organization, dedicated to innovate, manufacture and market high-quality healthcare products that enhance the quality of human life all over the globe, and in turn, increase shareholders value.

Walk-In Interview for Goa I & II Location.

Zydus Biologics or Zydus Healthcare Limited (also known as Zydus Cadila) is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat, India primarily engaged in the manufacture of generic drugs. It ranked 100th in the Fortune India 500 list in 2020. Cadila was founded in 1952 by Ramanbhai Patel (19252001), formerly a lecturer in the L.M. College of Pharmacy, and his business partner Indravadan Modi. It evolved over the next four decades into an established pharmaceutical company.

Medreich is a fully integrated pharmaceutical company with an established presence across the globe. The company is involved in the CMO & CDMO business of pharmaceutical preparations in various dosage forms catering to diverse Therapeutic categories.  Medreich has an advanced state of the art Research and Development centre with proven scientific competence to develop formulations as Patent Non-infringing and Niche generics in differentiated dosage form for global regulated markets.

Aspiro Pharma is one of the fastest growing Injectable Pharmaceutical company in India fully dedicated to research, development and manufacturing of Generic Parenteral Formulations (Lyophilized and Liquid products in the form of injectables, Pre-filled Syringes (PFS) and IV Bags) that find therapeutic application in treating a wide range of ailments. Aspiro Pharma is one of the leading USFDA approved pharmaceutical company (one of the fastest growing pharmaceutical company with global outreach) .

Encube is an integrated pharmaceutical company dedicated only to topical formulations viz. creams, ointments, gels, lotions, and solutions, with 24 years of formidable experience in contract development and manufacturing. Shri Mehul Shah, Promoter and Managing Director, incorporated Encube, on Sep 7, 1995, and commenced commercial operations on Mar 4, 1998.

Officer - Production
Qualification : B.Pharm
Experience : 1-3 Years